文献速递临床免疫临床微生物

全自动化学发光分析仪Liaison XL用于低结核发病率地区QuantiFERON-TB Gold Plus检测的性能评估

Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis.
PubMed 文献 · J Clin Microbiol · 2021-07-19

该研究在西班牙巴塞罗那一家三级教学医院比较了化学发光免疫分析仪Liaison XL与ELISA法在QuantiFERON-TB Gold Plus检测中的性能。2020年2月至4月共收集323名成年患者的333份肝素抗凝血样本。结果显示CLIA与ELISA一致性显著(κ=0.872),相关性好(r>0.950),且CLIA检测的IFN-γ值显著更高(TB1管P=0.004,TB2管P=0.010),多数ELISA不确定结果在CLIA上转为可解释结果。

要点

  • CLIA分析仪Liaison XL与ELISA法检测IFN-γ的一致性显著(κ=0.872),相关性好(r>0.950)。
  • CLIA检测的IFN-γ值显著高于ELISA(TB1管P=0.004,TB2管P=0.010)。
  • 多数ELISA不确定结果(8/15,53.3%)在CLIA上转为可解释结果。

核心结论

  • CLIA分析仪Liaison XL在检测IFN-γ方面表现良好,与ELISA法一致性显著且相关性好。
  • CLIA对潜伏性结核感染的识别可能具有更高敏感性,尤其在免疫受损患者中。
  • ELISA与CLIA方法间存在分析变异性,尤其在标准化的0.35-IU/ml阳性阈值附近,提示需完善判读算法。

研究设计与样本

  • 研究于2020年2月至4月在西班牙巴塞罗那一家三级教学医院进行。
  • 共收集323名成年患者的333份肝素抗凝血样本。
  • 比较化学发光免疫分析仪Liaison XL与ELISA法在QuantiFERON-TB Gold Plus检测中的性能。

主要发现

  • CLIA分析仪Liaison XL与ELISA法一致性显著(κ=0.872),相关性好(r>0.950)。
  • CLIA检测的IFN-γ值显著高于ELISA(TB1管P=0.004,TB2管P=0.010)。
  • 15例不一致结果中8例(53.3%)为ELISA不确定结果(NIL校正丝裂原值<0.5 IU/ml),经CLIA分析后转为可解释结果。

临床怎么用

  • 在低结核发病率地区,CLIA分析仪Liaison XL可作为QuantiFERON-TB Gold Plus检测中IFN-γ定量的替代方法。
  • 对于ELISA法不确定的结果,可考虑使用CLIA分析仪重新检测以获取可解释结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diagnosis of latent tuberculosis infection (LTBI) is considered key in the control of tuberculosis. Interferon gamma (IFN-γ) release assays, such as the QuantiFERON-TB Gold Plus test (QFT-Plus), are now widely implemented for the in vitro diagnosis of LTBI. To date, the detection and quantification of IFN-γ has been mostly performed with semiautomated enzyme-linked immunosorbent assays (ELISAs), but several limitations currently exist. The study aims to evaluate the chemiluminescence immunoassay (CLIA) analyzer Liaison XL compared to ELISA for the performance of the QFT-Plus test. Between February and April 2020, 333 heparin blood samples from 323 adult patients were collected at a tertiary teaching hospital in Barcelona, Spain. Overall, the CLIA analyzer Liaison XL performed well for the detection of IFN-γ compared to the ELISA method, demonstrating substantial agreement (κ, 0.872) and great correlation between assays (r, >0.950). CLIA produced significantly higher values of IFN-γ IU per milliliter than the ELISA (P = 0.004 for the TB1 tube and P = 0.010 for the TB2 tube). Many discrepant cases (8/15, 53.3%) corresponded to indeterminate results with ELISA (NIL-corrected mitogen value of <0.5 IU/ml), which, when analyzed with the CLIA analyzer Liaison XL, reverted to interpretable results. In conclusion, this analysis suggests that CLIA presents a greater sensitivity for the identification of LTBI, especially among immunocompromised patients. Furthermore, the analytical variability reported between both ELISA and CLIA methods, especially around the standardized 0.35-IU/ml positivity threshold, suggests the need to refine the interpretative algorithm.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Fernández-Huerta M, Moreto C, Vila-Olmo N, et al. Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis. J Clin Microbiol. 2021. PMID: 34076474. doi:10.1128/JCM.00603-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。